ICOSAPENT (is an active metabolite) | ICOSAPENT | NATURAL MOLECULE (link) CARDIOVASCULAR ADJUNCT TO DIET TO REDUCE TRIGLYCERIDE (TG) LEVELS IN ADULT PATIENTS WITH SEVERE (>= 500 MG/DL) HYPERTRIGLYCERIDEMIA POTENTIAL MECHANISMS OF ACTION INCLUDE INCREASED BETA-OXIDATION INHIBITION OF ACYL-COA:1,2-DIACYLGLYCEROL ACYLTRANSFERASE (DGAT) DECREASED LIPOGENESIS IN THE LIVER AND INCREASED PLASMA LIPOPROTEIN LIPASE ACTIVITY | - | VD 88 LITER PPB 99 PERCENT Cl 0.68 LITER / HOUR HT 89 HOUR | PDB 1IGX (CRYSTAL STRUCTURE OF EICOSAPENTANOIC ACID BOUND IN THE CYCLOOXYGENASE CHANNEL OF PROSTAGLANDIN ENDOPEROXIDE H SYNTHASE-1.) LIGAND CODE = EPA (link to the list of PDB complexes) Download experimental 3D coordinates of EPA with added hydrogens | Unknown more at DrugCentral | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |
ICOSAPENT ETHYL (has an active metabolite) | ICOSAPENT ETHYL | CARDIOVASCULAR ADJUNCT TO DIET TO REDUCE TRIGLYCERIDE (TG) LEVELS IN ADULT PATIENTS WITH SEVERE (>= 500 MG/DL) HYPERTRIGLYCERIDEMIA POTENTIAL MECHANISMS OF ACTION INCLUDE INCREASED BETA-OXIDATION INHIBITION OF ACYL-COA:1,2-DIACYLGLYCEROL ACYLTRANSFERASE (DGAT) DECREASED LIPOGENESIS IN THE LIVER AND INCREASED PLASMA LIPOPROTEIN LIPASE ACTIVITY | ORAL | | | Diacylglycerol O-acyltransferase 1 UNIPROT O75907 DGAT1 more at DrugCentral | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |